Friday, May 1, 2026

Samsung C&T’s 3 Billion USD Solar Project in Australia: A Game Changer for Renewable Energy?

Samsung C&T has successfully sold its first solar project outside the U.S. in Australia, marking a key milestone in renewable energy.

K-Food Expansion: How Korean Restaurants Are Conquering the U.S. Market

South Korean food brands expand globally, pivoting from China to the US, with strong growth in Japan and Vietnam despite challenges.

North Korea’s New Missiles Could Reach South Korea’s Heartland—Here’s the Latest Intel

South Korea's NIS revealed North Korea's new short-range ballistic missiles (SRBMs) have a 610 km range, reaching Chungcheong Province.

Tag: cancer research

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Solum Healthcare Announces AI-Based Urine Test for Cancer at AACR Annual Meeting 2026

Solum Healthcare presented AI-driven non-invasive cancer detection using urine samples at AACR 2026, attracting global interest and discussions.

How Dong-A ST’s SC5024 and ADC Innovations Could Change the Game Cancer Pipeline

Dong-A ST showcased its innovative cancer pipeline at AACR 2026, featuring promising preclinical findings and advanced therapeutic strategies.

How Hanmi’s Dual Inhibitor HM97662 is Revolutionizing Cancer Treatment: Key Insights from AACR 2026

Hanmi Pharmaceutical to present nine groundbreaking cancer research studies at AACR 2026, showcasing innovative therapies and AI-driven analytics.

How Samsung Medical Center is Revolutionizing Cancer Patient Care in Asia with EORTC Partnership

Samsung Medical Center's Cancer Hospital partners with EORTC to enhance cancer patients' quality of life through patient-reported outcomes.

Breakthrough Cancer Drug BAL0891: Key Findings to be Revealed at AACR 2026

SillaJen's cancer drug BAL0891 will be presented at the AACR 2026 conference, highlighting its effects on gastric and breast cancer models.

HLB Group Unveils Groundbreaking Cancer Treatments at AACR 2026: What You Need to Know

HLB Group will present key findings on anti-cancer therapies at AACR 2026, highlighting SynKIR-110 and Lirafugratinib's advancements.

How Tumor Microenvironment Stiffness Fuels Cancer Aggressiveness: Key Insights from Pusan National University

A study reveals that tumor microenvironment stiffness increases cancer aggressiveness and treatment resistance, highlighting its significance in treatment strategies.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.